pmid,title,journal,year,drug,disease
40283067,Effectiveness and Safety of Remdesivir for the Treatment of COVID-19 Patients with Liver Cirrhosis: A Retrospective Cohort Study.,"Life (Basel, Switzerland)",2025,Remdesivir,Cirrhosis
40160532,Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients.,PNAS nexus,2025,Remdesivir,Cirrhosis
39468309,Clinical usefulness of the serum levels of neuroinflammatory and lung fibrosis biomarkers in the assessment of cognitive dysfunction in post-COVID19 patients.,Scientific reports,2024,Remdesivir,Cirrhosis
39331891,Pharmacological targets and validation of remdesivir for the treatment of COVID-19-associated pulmonary fibrosis: A network-based pharmacology and bioinformatics study.,Medicine,2024,Remdesivir,Cirrhosis
39024326,Remdesivir alleviates skin fibrosis by suppressing TGF-beta1 signaling pathway.,PloS one,2024,Remdesivir,Cirrhosis
38793571,Challenges in Treating Pediatric Cancer Patients during the COVID-19 Pandemic: Balancing Risks and Care.,Viruses,2024,Remdesivir,Cirrhosis
38753462,The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.,Emerging microbes & infections,2024,Remdesivir,Cirrhosis
38368384,COVID-19 immune signatures in Uganda persist in HIV co-infection and diverge by pandemic phase.,Nature communications,2024,Remdesivir,Cirrhosis
38326193,Clinical characteristics and treatment outcomes among the hospitalized elderly patients with COVID-19 during the late pandemic phase in central Taiwan.,"Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi",2024,Remdesivir,Cirrhosis
38260306,Development of robust antiviral assays using relevant apical-out human airway organoids.,bioRxiv : the preprint server for biology,2024,Remdesivir,Cirrhosis
38179390,Relapsing COVID-19 in a Patient With Non-Hodgkin Lymphoma on Chemotherapy.,Cureus,2023,Remdesivir,Cirrhosis
37419691,Differential Effects of Remdesivir and Lumacaftor on Homomeric and Heteromeric hERG Channels.,Molecular pharmacology,2023,Remdesivir,Cirrhosis
37241068,Orthotopic Liver Transplantation of a SARS-CoV-2 Negative Recipient from a Positive Donor: The Border between Uncertainty and Necessity in a Pandemic Era- Case Report and Overview of the Literature.,"Medicina (Kaunas, Lithuania)",2023,Remdesivir,Cirrhosis
36914565,An important call: Suggestion of using IL-10 as therapeutic agent for COVID-19 with ARDS and other complications.,Virulence,2023,Remdesivir,Cirrhosis
36943958,Safe and Effective Use of Baricitinib and Remdesivir in Hospitalized Patients With Coronavirus (COVID-19).,,2025,Remdesivir,Cirrhosis
36852014,A case of COVID-19-associated fulminant myocarditis due to SARS-CoV-2 omicron BA.2 sub-lineage in an unvaccinated female.,Journal of cardiology cases,2023,Remdesivir,Cirrhosis
36755799,COVID-19 and atrial fibrillation: Intercepting lines.,Frontiers in cardiovascular medicine,2023,Remdesivir,Cirrhosis
36694123,COVID-19 associated acute transplant failure after AB0-incompatible living donor kidney transplantation - a case report.,BMC nephrology,2023,Remdesivir,Cirrhosis
36654476,Successful pediatric liver transplantation case with a positive SARS-CoV-2 test at the time of transplant.,Hepatology research : the official journal of the Japan Society of Hepatology,2023,Remdesivir,Cirrhosis
36401586,Fulminant myocarditis with COVID-19 infection having normal C-reactive protein and serial magnetic resonance follow-up.,ESC heart failure,2023,Remdesivir,Cirrhosis
36126219,Efficacy and Safety of Direct Hemoperfusion Using Polymyxin B-Immobilized Polystyrene Column for Patients With COVID-19: Protocol for an Exploratory Study.,JMIR research protocols,2022,Remdesivir,Cirrhosis
36083405,Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study.,Infection,2023,Remdesivir,Cirrhosis
36009549,Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study.,Biomedicines,2022,Remdesivir,Cirrhosis
35645319,TNF-alpha/IFN-gamma synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1.,Aging cell,2022,Remdesivir,Cirrhosis
35481309,Tocilizumab and Baricitinib for Recovery From Acute Exacerbation of Combined Pulmonary Fibrosis and Emphysema Secondary to COVID-19 Infection: A Case Report.,Cureus,2022,Remdesivir,Cirrhosis
35431501,"Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.",World journal of gastroenterology,2022,Remdesivir,Cirrhosis
35422381,Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs.,Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,2022,Remdesivir,Cirrhosis
35152259,Pulmonary Function and Chest Computed Tomography (CT) Scan Findings After Antifibrotic Treatment for COVID-19-Related Pulmonary Fibrosis.,The American journal of case reports,2022,Remdesivir,Cirrhosis
35084996,Pulmonary Aspects of COVID-19.,Annual review of medicine,2022,Remdesivir,Cirrhosis
35045989,Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial.,CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,2022,Remdesivir,Cirrhosis
34916057,Pneumothorax with Bullous Lesions as a Late Complication of Covid-19 Pneumonia: A Report on Two Clinical Cases.,The Journal of emergency medicine,2021,Remdesivir,Cirrhosis
34512328,Protective Effect of Remdesivir Against Pulmonary Fibrosis in Mice.,Frontiers in pharmacology,2021,Remdesivir,Cirrhosis
34447688,Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care.,Journal of clinical and translational hepatology,2021,Remdesivir,Cirrhosis
34328629,Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP).,Infectious diseases and therapy,2021,Remdesivir,Cirrhosis
34276356,Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys.,Frontiers in pharmacology,2021,Remdesivir,Cirrhosis
34243049,Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review.,Journal of infection and public health,2021,Remdesivir,Cirrhosis
33883098,SARS-CoV-2 and Burkholderia cenocepacia infection in a patient with Cystic Fibrosis: An unfavourable conjunction?,Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,2021,Remdesivir,Cirrhosis
33712855,Usage experience of remdesivir for SARS-CoV-2 infection in a patient with chronic cirrhosis of Child-Pugh class C.,The Journal of antimicrobial chemotherapy,2021,Remdesivir,Cirrhosis
33534931,Mortality is not increased in SARS-CoV-2 infected persons with hepatitis C virus infection.,Liver international : official journal of the International Association for the Study of the Liver,2021,Remdesivir,Cirrhosis
33407777,"Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.",Trials,2021,Remdesivir,Cirrhosis
33398223,Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know?,Journal of clinical and experimental hepatology,2021,Remdesivir,Cirrhosis
33397449,"Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).",Trials,2021,Remdesivir,Cirrhosis
33362383,Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective.,World journal of gastroenterology,2020,Remdesivir,Cirrhosis
33356661,Natural history of COVID-19 and therapeutic options.,Expert review of clinical immunology,2020,Remdesivir,Cirrhosis
33316266,Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-beta signalling in COVID-19 survivors.,Life sciences,2021,Remdesivir,Cirrhosis
33155953,"[Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial ""BromhexIne and Spironolactone for Coronsmall a, CyrillicvirUs Infection requiring hospiTalization (BISCUIT)""].",Kardiologiia,2020,Remdesivir,Cirrhosis
32891697,Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?,Biochimie,2020,Remdesivir,Cirrhosis
32727662,COVID-19 and liver disease: An update.,Gastroenterologia y hepatologia,2020,Remdesivir,Cirrhosis
32698440,Tiotropium is Predicted to be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis.,Viruses,2020,Remdesivir,Cirrhosis
32564624,Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation.,Annals of Saudi medicine,2020,Remdesivir,Cirrhosis
